Trial intelligence / Profile preview

UC-MSC Dressing for Oral cGVHD

NCT06149832Phase 4Unknown

Sponsor
Southwest Health System
Start
Nov 2023
Primary completion
Nov 2023
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 4 trial of human umbilical cord mesenchymal stem cells in chronic graft-versus-host disease (cGVHD), sponsored by Southwest Health System. Status: unknown.

02

Drugs

human umbilical cord mesenchymal stem cells
03

Conditions

chronic graft-versus-host disease (cGVHD)

Beyond the preview

Go deeper on NCT06149832.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06149832.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call